APPLICATIONS PUBLISHED 21 JANUARY 2003
Published: 1-Jul-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
Control Delivery System 1276462*
Hemostatic agent, method and carrier for applying a blood clotting agent
Biolife 1276463*
Improved water-insoluble drug particle process
RTP Pharma 1276465*
Directly compressed solid dosage particles
Noveon IP Holdings 1276466*
Guaifenesin sustained release formulation and tablets
Adams Laboratories 1276467*
Use of particulate vectors in immunomodulation
Biovector Therapeutics; Institut Gustave Roussy 1276468*
Taste masking coating compsn
Bristol-Myers Squibb 1276469*
Taste masking coating compsn
Bristol-Myers Squibb 1276470*
Membrane delivery system
Color Access 1276471*
Formulations for use in inhaler devices
Vectura 1276472*
Pharmaceutical compsn for dry powder inhalers
Vectura 1276473*
Formulations for use in inhaler devices
Vectura 1276474*
Topical anaesthetic/opioid formulations and uses thereof
Memorial Sloan-Kettering Cancer Centre 1276475*
Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
Boehringer Ingelheim 1276476*
Medicaments containing pantothenic acid for the treatment of inflammatory joint disease
Britannia Pharmaceuticals 1276477*
(2-aminoethyl) oxime derivatives for the treatment of depression
ARYx Therapeutics 1276478*
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
SuperGen 1276479*
Process of making racemic bupivacaine's enantiomers, levobupivacaine's pharmaceutical compsns; levobupivacaine's pharmaceutical compsns formulated on its free base form or its pharmaceutically acceptable salts and use of levobupivacaine's pharmaceutical compsns formulated on its free BA
Cristalia Productos Quimicos e Farmaceuticos 1276480*
Daily treatment for erectile dysfunction using a PDE5 inhibitor
Lilly Icos 1276481*
Combination chemotherapy
University of Pittsburgh of the Commonwealth System of Higher Education 1276482*
Compsns and methods for treating amyloidosis using sulphonate derivatives
Queen's University at Kingston; Neurochem 1276483*
Medicine containing polysaccharide substances for activating apoptosis
Laboratoires Goemar 1276484*
Compsns useful in the treatment of diseases of connective tissue comprising a ferrous ion and an ascorbate
Ocean Nutrition Canada 1276485*
Joint repair using mesenchymal stem cells
Osiris Therapeutics 1276486*
Treatment of conditions of the central nervous system using mycobacteria
Stanford Rook 1276487*
Use of lactic acid bacterium for the treatment of peritonitis
Societe des Produits Nestle 1276488*
Novel medicines based on sesquiterpene mixtures
Rougereau-Person, Odile; Rougereau, Andre 1276489*
Novel Borrelia burgdorferi polypeptides and uses thereof
Tufts University 1276490*
Tamadarin and dideminin analogues and methods of making and using the same
The Trustees of the University of Pennsylvania 1276491*
P43 antigen for the immunodiagnosis of canine ehrlichosis and uses thereof
Research Development Foundation 1276492*
CXCR4 agonist treatment of haematopoietic cells
The University of British Columbia; Chemokine Therapeutics 1276493*
A memory enhancing protein
Saktor, Todd 1276494*
Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
Altana Pharma 1276495*
Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
Pfizer Products 1276496*
Mixture of defibrotide and G-CSF and its use for activating haematopoietic progenitors
Crinos Industria Farmacobiologica 1276497*
Use of NPY Y1 receptor antagonists in the treatment of inflammatory conditions
Karolinska Innovations 1276498*
Equine protozoal, myeloencephalitis vaccine
Wyeth 1276499*
Blocking leukocyte emigration and inflammation by interfering with CD99/HEC2
Cornell Research Foundation 1267500*
Method for treatment of tumours using photodynamic therapy
Immunex Corp 1276501*
Single-dose antihistamine/decongestant formulations for treating rhinitis
J-Med Pharmaceuticals 1276502*
Compsns comprising an inhibitor of an Acrab-like efflux pump for reducing microbial resistance to drugs
Trustees of Tufts College 1276503*
Medicines for treating tumoral pathologies containing the RO5-4864 compound and an apoptosis-inducing agent
Centre National de la Recherche Scientifiques (CNRS) 1276504*
Mixtures of triblock polyester-polyethylene glycol copolymers
MacroMed 1276505*
Sustained release drug compsns
LTT Institute 1276506*
High affinity peptide-containing nanoparticles
Alnis Biosciences 1276507*
A particulate complex for administering nucleic acid into a cell
Biovector Therapeutics 1276508*
